Patents and biodiversity: crossing the divide
The Indian Patent Office has attempted to bridge the divide between the laws on patents and biological diversity, but instead it created a maze of problems, says Vidisha Garg of Anand and Anand.
Latest news
FDA identifies companies ‘potentially blocking access’ to drug samples
21-05-2018
The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.
Novartis acquires gene therapy company
18-05-2018
50 Key Influencers In The Life Sciences
Regions
Sectors
